Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,310.71p
   
  • Change Today:
    -14.29p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 34
  • Market Cap: £225.00m
  • Beta: 0.04

Latest Deals

Traded Action Notifier PriceAmountValue
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £12,806,615
Ian James Nicholson 13,000 £560,393
Bruce Hiscock 789 £34,012

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £225,004,457
Castlefield Fund Partners Limited 985,000 £42,460,536
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £38,149,821
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £26,704,875
Gresham House Asset Management Limited 577,782 £24,906,531
Miton Group plc 508,135 £21,904,248
The Diverse Income Trust plc 302,300 £13,031,289
Wasatch Advisors, Inc. 265,000 £11,423,393
Canaccord Genuity Group Inc 259,940 £11,205,271
Adrian Williams 253,372 £10,922,143

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,310.71p
Change Today -14.29p
% Change -0.33 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 34
Shares Issued 5.22m
Market Cap £225.00m
Beta 0.04

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
75.35% above the market average75.35% above the market average75.35% above the market average75.35% above the market average75.35% above the market average
92.73% above the sector average92.73% above the sector average92.73% above the sector average92.73% above the sector average92.73% above the sector average
Income
13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
33.48% below the market average33.48% below the market average33.48% below the market average33.48% below the market average33.48% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 03-May-2024

Time Volume / Share Price
09:22 10 @ 4,325.00p
09:02 23 @ 4,325.00p
08:10 1 @ 4,341.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page